[Burning mouth syndrome].
Burning mouth syndrome (BMS) is characterized by burning sensations of the oral cavity in the absence of abnormalities of the oral mucosa. BMS predominantly affects middle-aged women. This condition has a multifactorial etiology. Multiple approaches to treatment have been described. This article examines BMS, its related factors, and treatment options.
Scardina
Giuseppe Alessandro
GA
Dipartimento di Scienze Stomatologiche G. Messina, Sezione di Odontostomatologia, Università, Palermo. scardina@odonto.unipa.it
Pisano
Teresa
T
Messina
Pietro
P
D000367:Age Factors; D000368:Aged; D000588:Amines / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use; D002054:Burning Mouth Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D000077206:Gabapentin; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012737:Sex Factors; D008063:Thioctic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D014151:Anti-Anxiety Agents; D000975:Antioxidants; D003509:Cyclohexanecarboxylic Acids; D014803:Vitamin B Complex; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D008063:Thioctic Acid